Introduction {#sec0005}
============

A prostate abscess caused by *Nocardia* is rare. We present the first case of a prostate abscess caused by *Nocardia farcinica* in a man who had been on long term steroids and etanercept for severe psoriasis and psoriatic arthritis.

Case presentation {#sec0010}
=================

A 68 year old man presented in March 2015 with a one week history of intermittent dysuria and suprapubic pain. He had a two day history of urinary hesitancy, fever, vomiting, diarrhoea and dyspnoea. Three weeks previously he cut his left middle finger whilst gardening. This became infected and required a one week course of amoxicillin.

He has been heavily immunosuppressed for 30 years for severe psoriasis and psoriatic arthritis. He has been on prednisolone 10 mg daily and etanercept 50 mg weekly for the past 5 years. His previous immunosuppressive agents include methotrexate and leflunomide. His other medical history includes asthma, hypertension, steroid-induced diabetes and atrial fibrillation. There was no history of any prostate surgery or instrumentation.

On admission he looked unwell. His observations were heart rate 167, blood pressure 163/75 mmHg, respiratory rate 22, oxygen saturations 97% on room air and a temperature of 38.2 °C. On examination he had right base crepitations and suprapubic tenderness. Urine analysis was positive for blood. His urine microscopy showed 30 white blood cells but no growth. His chest x-ray showed no consolidation. The C reactive protein was 390 mg/L with a white cell count of 24.9 × 10 to 9/L. He was empirically treated with ceftriaxone, gentamicin and flucloxacillin in the emergency department for sepsis of unknown source. His acute medical unit admission diagnosis was likely urosepsis and was continued on ceftriaxone only. His etanercept was held but his prednisolone dose was increased to 37.5 mg.

Two days into his admission he developed urinary retention requiring catheterisation. A rectal exam revealed a tender prostate. A computed tomography (CT) scan identified "a 3.6 × 3 × 3.4 cm left prostate abscess and a possible sub-centimetre abscess involving the right prostate gland ([Fig. 1](#fig0005){ref-type="fig"})". His antibiotics were then changed to intravenous ciprofloxacin 500 mg twice a day.

On day 6 his blood cultures grew *N. farcinica (*taken pre-antibiotics on day 1). The identification was performed by 16 s rRNA gene sequencing. Trimethoprim and sulfamethoxazole (TMP-SMX) were additionally commenced. Two further blood cultures taken on day 7 and 10 had no growth. A CT chest and brain found no evidence of *Nocardia* seeding although a 5 mm soft tissue nodule was noted in the right lower lobe.

He responded to treatment and his inflammatory markers normalised. He was discharged home after 15 days on oral ciprofloxacin and TMP-SMX. The etanercept was held indefinitely and prednisolone weaned back to his normal dose. He has currently been on antibiotics for 8 months and his repeat CT showed his prostate abscess had resolved.

Discussion {#sec0015}
==========

Prostate infections are most commonly caused by Gram-negative organisms associated with urinary tract infections or *Staphylococcus aureus* from haematological dissemination from a primary focus. There are no literature case reports of a prostate abscess caused by *Nocardia*. There are 7 case reports of epidiymo-orchitis and/or testicular abscesses caused by *Nocardia* and one disseminated *Nocardia* infection associated with a urinary tract infection. In all cases, except for one, the patients were immunosuppressed with steroids [@bib0005], [@bib0010], [@bib0015], [@bib0020], [@bib0025], [@bib0030], [@bib0035], [@bib0040].

*Nocardia* is characterised as a Gram positive filamentous rod and is found worldwide in soil, decaying vegetable matter and aquatic environments [@bib0045]. It is a slow growing organism and can take up to 7 days to be identified on blood cultures. The genus of *Nocardia* is rapidly expanding and now contains more than 50 known species. Identification of clinical isolates beyond the genus level is important since *Nocardia* species differ in the clinical spectrum of the disease they cause and their susceptibility to antibiotics. In particular, *N. farcinica* tends to be more virulent resulting in disseminated disease and increased resistance to treatment [@bib0050], [@bib0055], [@bib0060].

Sixty percent of all reported cases of *Nocardia* are associated with underlying immunosuppression [@bib0050]. The overall incidence of *Nocardia* in different types of immunosuppressed populations has been estimated to range between 0.4% and 3.6% [@bib0050]. In the literature, solid organ transplants are the most common underlying associated condition followed by HIV infection [@bib0060]. Minero et al. found that treatment with corticosteroids was the most important risk factor; 62% (N = 23) had received corticosteroids for a median of 3 months with a median dose of 25 mg before developing *Nocardia* [@bib0050].

The main route of acquisition is through direct inhalation of airborne spores or by direct inoculation through the skin. *Nocardia* involves the lung in 60--70% of cases and skin in 10%. However, it can affect virtually any organ through haematological dissemination, most commonly the central nervous system [@bib0050], [@bib0055]. *Nocardia* isolation from blood cultures is rare (even with disseminated disease) and has been associated with central venous catheters and prosthetic heart valves, neither of which our patient had [@bib0060]. *Nocardia* bacteraemia carries a high mortality rate of 50--85% [@bib0060], [@bib0065].

Cutaneous *Nocardia* is characterised by one of two manifestations: primary cutaneous infection via inoculation or disseminated infection with skin involvement. Primary cutaneous infection more commonly affects immunocompetent individuals; the most common isolated species being *N. brasiliensis* [@bib0070]. In our case we presumed he acquired *Nocardia* through skin inoculation whilst gardening with haematological dissemination to his prostate. Although the most common radiological finding of pulmonary *Nocardia* is a lung nodule we did not get a biopsy to confirm a tissue diagnosis as the patient was responding to treatment [@bib0075].

General treatment recommendations for *Nocardia* are hindered by lack of prospective controlled trials. TMP-SMX is recommended as an initial empiric regimen since most studies show high rates of susceptibility of *Nocardia* to this combination [@bib0060]. The duration is prolonged to minimise risk of disease relapse; the mean duration of treatment is 6--12 months but should be tailored to the underlying immunosuppression and clinical progression of the patient [@bib0075].

We accept that a limitation of this case was that we were unable to obtain a tissue diagnosis. Unfortunately, both the interventional radiology and urology teams were reluctant to perform a transrectal drainage given the high risk of a fistula and further seeding. The second limitation is that we did not culture the organism from a second set of blood culture and this is because he was empirically started on broad-spectrum antibiotics on admission. *Nocardia* species in blood culture is rarely considered a contaminant especially in patients presenting with sepsis in the background of profound immunosuppression [@bib0080].

Conclusion {#sec0020}
==========

*Nocardia* has a rising incidence due to increasing numbers of immunosuppressed patients and improved methods of detection [@bib0060]. Early detection and treatment of patients is clinically important due to its high mortality. This case report serves to highlight the importance of early, pre-antibiotic blood cultures and the necessity for clinicians to consider unusual presentations of opportunistic infections in immunocompromised patients.
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